Unlock stock picks and a broker-level newsfeed that powers Wall Street.

HKSE - Delayed Quote HKD

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989.HK)

Compare
4.360
-0.080
(-1.80%)
At close: 4:08:01 PM GMT+8
Currency in CNY All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
5,280,713.411
5,280,713.411
5,445,572.060
7,159,410.684
6,365,177.483
Cost of Revenue
3,524,558.247
3,524,558.247
3,645,268.748
4,825,009.753
4,332,138.396
Gross Profit
1,756,155.164
1,756,155.164
1,800,303.312
2,334,400.932
2,033,039.087
Operating Expense
1,013,647.920
1,013,647.920
1,160,308.244
1,211,852.274
1,068,874.395
Operating Income
742,507.244
742,507.244
639,995.068
1,122,548.658
964,164.692
Net Non Operating Interest Income Expense
-109,115.293
-109,115.293
-199,175.028
-203,087.706
-162,846.721
Pretax Income
726,229.258
726,229.258
-928,333.835
829,850.959
222,262.937
Tax Provision
101,311.222
101,311.222
-126,174.605
114,815.764
-11,120.488
Net Income Common Stockholders
646,741.666
646,741.666
-783,258.039
727,425.655
240,787.579
Basic EPS
0.44
--
-0.53
0.50
0.16
Diluted EPS
0.44
--
-0.53
0.50
0.16
Basic Average Shares
1,467,199.788
--
1,467,324.915
1,468,063.885
1,467,322.234
Diluted Average Shares
1,467,199.788
--
1,467,324.915
1,468,063.885
1,467,322.234
Total Operating Income as Reported
741,310.976
741,310.976
-860,910.894
828,623.185
227,474.698
Total Expenses
4,538,206.167
4,538,206.167
4,805,576.992
6,036,862.027
5,401,012.791
Net Income from Continuing & Discontinued Operation
646,741.666
646,741.666
-783,258.039
727,425.655
240,787.579
Normalized Income
711,429.168
711,429.168
67,246.387
876,077.108
466,678.542
Interest Income
44,374.948
44,374.948
39,521.460
54,138.639
54,856.869
Interest Expense
141,184.426
141,184.426
223,219.338
235,242.067
201,630.986
Net Interest Income
-109,115.293
-109,115.293
-199,175.028
-203,087.706
-162,846.721
EBIT
867,413.684
867,413.684
-705,114.497
1,065,093.026
423,893.923
EBITDA
1,198,464.859
1,198,464.859
-331,518.476
1,372,752.482
726,638.625
Reconciled Cost of Revenue
3,524,558.247
3,524,558.247
3,645,268.748
4,825,009.753
4,332,138.396
Reconciled Depreciation
331,051.175
331,051.175
373,596.020
307,659.456
302,744.702
Net Income from Continuing Operation Net Minority Interest
646,741.666
646,741.666
-783,258.039
727,425.655
240,787.579
Total Unusual Items Excluding Goodwill
-75,174.588
-75,174.588
-984,283.427
-172,520.949
-301,187.952
Total Unusual Items
-75,174.588
-75,174.588
-984,283.427
-172,520.949
-301,187.952
Normalized EBITDA
1,273,639.447
1,273,639.447
652,764.951
1,545,273.431
1,027,826.576
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-10,487.087
-10,487.087
-133,779.001
-23,869.497
-75,296.988
12/31/2021 - 7/8/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade